Volume 51, Issue 2 pp. 273-282
REVIEW

Maternal hyperoxygenation during pregnancy as a tool in fetal disease diagnosis and treatment

Agnieszka Zalinska

Agnieszka Zalinska

Department of Prenatal Cardiology, Polish Mother's Memorial Hospital Research Institute, Lodz, Poland

Department of Obstetrics and Perinatology, Chair of Obstetrics, Gynecology and Oncological Gynecology, Medical University of Lodz, Lodz, Poland

Search for more papers by this author
Maria Respondek-Liberska

Maria Respondek-Liberska

Department of Prenatal Cardiology, Polish Mother's Memorial Hospital Research Institute, Lodz, Poland

Department of Diagnosis and Prevention of Fetal Malformations, Medical University of Lodz, Lodz, Poland

Search for more papers by this author
Maciej Slodki

Corresponding Author

Maciej Slodki

Department of Prenatal Cardiology, Polish Mother's Memorial Hospital Research Institute, Lodz, Poland

Faculty of Health Sciences, The Mazovian State University, Plock, Poland

Correspondence

Maciej Slodki, Department of Prenatal Cardiology, Polish Mother's Memorial Hospital Research Institute, Lodz, Poland.

Email: [email protected]

Search for more papers by this author
First published: 13 February 2023
Citations: 1

Abstract

Maternal hyperoxygenation (MHO) consists of giving pregnant women (60% to 100%) oxygen through a facemask and using ultrasound assess or monitor the influence on fetal cardiovascular circulation. This review discusses the findings and the utility of acute and chronic MHO in various fetal diseases.

DATA AVAILABILITY STATEMENT

The data that support the findings of this study are available from the corresponding author upon reasonable request.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.